Markets - Page 202

By Market Capitalisation.Net Sales.Net Profit.Total Assets.Excise.Other Income.Raw Materials.Power & Fuel.Employee Cost.PBDIT.Interest.Tax.EPS.Investments.Sundry Debtors.Cash/Bank.Inventory.Debt.Contingent Liabilities. Screen Crit AbrasivesAerospace & DefenceAgricultureAir ConditionersAirlinesAluminium & Aluminium ProductsAmusement Parks/Recreation/ClubAquacultureAuto AncillariesAuto Ancillaries – Air Conditioning PartsAuto Ancillaries – Auto,

Traders work on the floor of the New York Stock Exchange on Feb. 13, 2025. Danielle DeVries | CNBC Stock futures are near flat Thursday night as investors looked to the end

Permutable AI, a specialist in LLM-driven market sentiment analysis today announced the launch of Market 360, a market sentiment visualisation tool that provides a comprehensive 360-degree view across commodity and FX markets

The owner of London Stock Exchange expects continued growth and ‘improving profitability’ this year, despite the ongoing weakness of its domestic bourse.  The LSE has seen an exodus of big names in

Here is what you need to know on Thursday, February 27: The US Dollar (USD) stays resilient against its peers in the European morning on Thursday as market participants gear for key

Good morning! It has been a busy week for updates, let’s see what’s in store for us today. The Agenda is under construction. Let’s kick things off with a backlog section from

Over the past few years, the South African and US stock markets have become dominated by a few large-cap stocks. Such concentration bodes ill for investors in terms of diversification. The concentration

Volatility is the name of the game when it comes to crypto markets, and this week offered participants more of the same: an $800 billion rout since January. The price of bitcoin

CME Group, the world’s leading derivatives marketplace, reported it reached a new, single-day volume record of 67,124,571 contracts traded on February 25. This surpasses the previous record of 66,256,756 contracts set on

The global hemoglobinopathies market size was valued at USD 10.52 billion in 2024 and is projected to reach USD 34.76 billion by 2034, registering a CAGR of 12.7% from 2025 to 2034.